D'Ugo, Domenico
 Distribuzione geografica
Continente #
NA - Nord America 3.799
EU - Europa 3.771
AS - Asia 1.435
AF - Africa 28
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 9.057
Nazione #
US - Stati Uniti d'America 3.760
DE - Germania 1.218
SE - Svezia 721
IT - Italia 641
CN - Cina 599
SG - Singapore 456
UA - Ucraina 291
IE - Irlanda 224
FR - Francia 221
GB - Regno Unito 150
ID - Indonesia 149
IN - India 84
RU - Federazione Russa 81
TR - Turchia 76
FI - Finlandia 61
BE - Belgio 32
CA - Canada 27
CI - Costa d'Avorio 25
NL - Olanda 23
ES - Italia 18
HK - Hong Kong 17
AT - Austria 15
PL - Polonia 15
CZ - Repubblica Ceca 14
IR - Iran 12
JP - Giappone 11
VN - Vietnam 10
MX - Messico 9
LT - Lituania 8
CH - Svizzera 7
DK - Danimarca 7
KR - Corea 6
RO - Romania 6
GR - Grecia 5
AU - Australia 4
EU - Europa 4
PT - Portogallo 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
BR - Brasile 3
CL - Cile 3
IL - Israele 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
RS - Serbia 3
BD - Bangladesh 2
DZ - Algeria 2
VG - Isole Vergini Britanniche 2
A1 - Anonimo 1
EE - Estonia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
Totale 9.057
Città #
Chandler 1.049
Singapore 350
Ashburn 289
Dublin 222
San Mateo 188
Jacksonville 169
Jakarta 148
Wilmington 146
Milan 124
Nanjing 118
Ann Arbor 100
Princeton 90
New York 87
Rome 85
Nürnberg 78
Beijing 75
Cattolica 64
Izmir 64
Moscow 63
Dearborn 62
Munich 58
Woodbridge 57
Marseille 55
Boston 54
Houston 50
Fairfield 47
Los Angeles 43
Verona 43
Zhengzhou 41
Lawrence 39
Nanchang 36
Boardman 35
Bremen 35
Redwood City 34
Brussels 32
Lancaster 31
Mountain View 31
Norwalk 31
Seattle 31
Shenyang 27
Abidjan 25
Tianjin 20
Changsha 19
Hebei 19
Helsinki 17
Hong Kong 17
Cambridge 16
Shanghai 16
Amsterdam 15
Augusta 15
Kunming 15
Leawood 15
Busto Arsizio 14
Hangzhou 14
London 14
Falkenstein 13
Redmond 13
Salò 11
Toronto 11
Warsaw 11
Andover 10
Nuremberg 10
Ottawa 10
Paris 10
Washington 10
Chicago 9
Jiaxing 9
Berlin 8
Frankfurt am Main 8
Fremont 8
Guangzhou 8
Jinan 8
Lanzhou 8
Pune 8
University Park 8
Vienna 8
Brno 7
Edinburgh 7
Retamar 7
Falls Church 6
Hefei 6
Kish 6
Monza 6
Ningbo 6
San Francisco 6
Tokyo 6
Bern 5
Cuauhtémoc 5
Dong Ket 5
Hanoi 5
Santa Clara 5
Bangkok 4
Bari 4
Buk-gu 4
Chengdu 4
Costa Mesa 4
Fuzhou 4
Phoenix 4
Qingdao 4
Rosignano Marittimo 4
Totale 4.955
Nome #
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 383
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 206
A case-control study on the effect of Apolipoprotein E genotypes on gastric cancer risk and progression 189
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 164
The Road to Curative Surgery in Gastric Cancer Treatment: A Different Path in the Elderly? 162
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 139
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 136
Education and imaging: gastrointestinal: videocapsule retention: rationale for surgical indication 126
cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer 125
R0 resection in the treatment of gastric cancer: room for improvement 118
Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer 115
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 112
Harlequin Syndrome 112
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 111
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 106
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives 105
Large bowel auto-amputation and passage of a colon 'cast' after left hemicolectomy 104
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 100
Susceptibility to Helicobacter pylori infection: results of an epidemiological investigation among gastric cancer patients 100
Prognostic value of preoperative staging in gastric cancer 99
Surgery in COVID-19 patients: Operational directives 99
null 96
Determinants of surgical morbidity in gastric cancer treatment 95
Metastatic lymph node ratio: a new staging system for gastric cancer 94
Therapeutic implications of mesenchymal stem cells in liver injury 92
Prognostic Value of Preoperative Staging in Gastric Cancer 91
Acute pancreatitis associated with primary hyperparathyroidism 91
Giant inflammatory polyposis as the first manifestation of inflammatory bowel disease 91
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 91
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 89
Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery 89
Transanal Total Mesorectal Excision vs Laparoscopic Total Mesolectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. 89
The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies 86
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 85
The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review 85
Perioperative chemotherapy for gastric cancer: how should we measure the efficacy? 83
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 81
REGATTA trial: a call for the USA and Europe 81
Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? 80
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 80
Do perioperative blood transfusions influence prognosis of gastric cancer patients? Analysis of 927 patients and interactions with splenectomy 79
Tumor size as a prognostic factor in patients with stage IIa colon cancer 77
Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer 76
Intraoperative esophageal manometry in surgical treatment of achalasia: a reappraisal. 75
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 75
The "Lazio Network" experience. The first Italian regional research group on the Enhanced Recovery After Surgery (ERAS) program. A collective database with 1200 patients in 2016-2017 74
The learning curve of TaTME for mid-low rectal cancer: a comprehensive analysis from a five-year institutional experience 74
Risk factors for wound complications in patients undergoing primary closure of the perineal defect after total proctectomy 73
Limited lymph node dissection and metastatic lymph node ratio: a wave of trust 72
Preoperative treatment and surgery in gastric cancer: friends or foes? 71
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer 71
D1-plus vs D2 nodal dissection in gastric cancer: A propensity score matched comparison and review of published literature 71
Follow-up: the evidence 70
Gastric cancer: Current status of lymph node dissection 69
3D pelvimetry and biometric measurements: a surgical perspective for colorectal resections 69
Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse 66
Krukenberg tumors: Seed, route and soil 66
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 66
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 66
Association between colorectal cancer and streptococcus gallolyticus subsp. pasteuranus (former s. bovis) endocarditis: Clinical relevance and cues for microbiota science. case report and review of the literature 64
Impact of the latest TNM classification for gastric cancer: retrospective analysis on 94 D2 gastrectomies. 62
Synchronous gastric adenocarcinoma and MALT lymphoma in a patient with H. pylori infection. Could the two neoplasms share a common pathogenesis? 61
Transesophageal echocardiographic assessment of hemodynamic function during laparoscopic cholecystectomy in healthy patients. 61
Towards the goal of r0 resection in locally advanced gastriccancer through the path of neoadjuvant chemotherapy e impact of tumour downstaging on survival in a single series. 60
Italian multi-society modified Delphi consensus on the definition and management of anastomotic leakage in colorectal surgery 60
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 60
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer 59
Impact of Diagnostic laparoscopy on the managment of gastic cancer: prospective study of 120 consecutive patients with primary gastric adenocarcinoma 58
Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery--Varese (Italy), December 2, 2011 58
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 58
Beyond the Guidelines: The Grey Zones of the Management ofGastric Cancer. Consensus Statements from the Gastric CancerItalian Network (GAIN) 58
Nutricatt protocol improves body composition and clinical outcomes in elderly patients undergoing colorectal surgery in eras program: A retrospective cohort study 58
Feasibility of discharge within 72 hours of major colorectal surgery: lessons learned after 5 years of institutional experience with the ERAS protocol 58
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 56
Image of the month--quiz case. 55
Enhanced Recovery Program for Colorectal Surgery: a Focus on Elderly Patients Over 75 Years Old 55
Achieving high quality standards in laparoscopic colon resection for cancer: A Delphi consensus-based position paper 55
Surgical issues after neoadjuvant treatment for gastric cancer 53
Totally laparoscopic right colectomy versus laparoscopically assisted right colectomy: a propensity score analysis 53
Fashioning enterotomy closure after totally laparoscopic ileocolic anastomosis for right colon cancer: a multicenter experience 53
A word for equity: the long road ahead 53
One-year evaluation of anorectal functionality and quality of life in patients affected by mid-to-low rectal cancer treated with transanal total mesorectal excision 53
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database 52
Follow-up after gastrectomy for cancer: an appraisal of the italian research group for gastric cancer 52
Laparoscopic staging of gastric cancer: an overview. 52
Neoadjuvant chemotherapy and ongoing-trials 51
3D MRI segmentation and 3D circumferential resection margin evaluation for a standard rectal cancer assessment 51
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 51
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis 51
Imagine a world without cancer 49
Quality Over Volume: Modeling Centralization of Gastric Cancer Resections in Italy 49
Neoadjuvant chemotherapy in gastric carcinoma 48
Chimera fully covered self-expandable metal stent for refractory esophageal anastomotic leak 48
Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study 48
Prevalence of thyroid carcinoma in toxic goiter 47
Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study 45
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 45
Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment 45
Prognostic Indicators in Stage IV Surgically Treated Gastric Cancer Patients: A Retrospective Multi-Institutional Study 44
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO) 44
Totale 8.133
Categoria #
all - tutte 46.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020476 0 0 0 0 0 0 136 23 89 70 95 63
2020/2021920 35 71 6 67 78 68 137 6 197 78 137 40
2021/20221.129 169 62 18 129 37 16 16 195 35 63 193 196
2022/20232.576 339 339 193 421 157 320 104 194 351 27 97 34
2023/20241.189 58 337 34 62 44 135 71 22 18 81 140 187
2024/20251.004 50 73 245 195 336 101 4 0 0 0 0 0
Totale 9.360